Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER

With Its New Marijuana Deal, Is Cigarette-Maker Altria Group Finally A Buy?

By Investing.com (Haris Anwar/Investing.com)Stock MarketsDec 12, 2018 02:15AM ET
www.investing.com/analysis/altria-group-a-buy-after-marijuana-deal-200367241/
With Its New Marijuana Deal, Is Cigarette-Maker Altria Group Finally A Buy?
By Investing.com (Haris Anwar/Investing.com)   |  Dec 12, 2018 02:15AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-1.30%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MO
+0.82%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BUD
+0.15%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CRON
-2.01%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

After watching its market cap steadily erode over the past year and a half, Altria Group (NYSE:MO), the owner of Marlboro cigarettes among other globally recognized tobacco brands, is at long last fighting back.

MO Weekly 2015-2018
MO Weekly 2015-2018


Last week, the parent company of Philip Morris USA, Skoal and Nat Sherman announced that it was paying $1.8 billion for a 45% stake in Canadian cannabis company Cronos Group (NASDAQ:CRON). The deal also allows the cigarette maker to acquire another 10% of the Toronto-based Cronos, a move that would give Altria a controlling stake in the pot producer in its home country, which in October became the first developed nation to legalize marijuana for adult recreational use.

Even before its entry into the marijuana market, Altria was reported to be in talks for a minority stake in an e-cigarette startup, Juul Labs Inc. Both moves appear to be part of a larger diversification strategy for this traditional tobacco company, a way to revive growth at a time when cigarette sales are declining and nicotine consumers are increasingly looking for other options in lieu of burning tobacco.

New Avenues For Growth

This aggressive, acquisition-led growth strategy comes on the heels of steep declines in Altria shares, which closed yesterday at $53.95. Since the summer of 2017, Altria has lost more than a quarter of its market capitalization, as technological innovation, new government regulations and declining adult consumption of traditional tobacco products created doubts about the company’s future growth potential.

Nearly 38 million, or 15.5%, of American adults smoked traditional cigarettes in 2016, down from 20.9% in 2005, according to the US's Centers for Disease Control and Prevention. This shift in tobacco consumption has also been bad news for long-time Altria investors, who for years have loved the stock for its recession-proof status and attractive dividends.

Indeed, during the past decade, Altria shares have outperformed the benchmark S&P 500 by a wide margin, providing stakeholders with annualized returns of about 20%, through January 2018. However, since the start of the year that advantage has been shrinking rapidly, forcing management to seek new avenues for growth.

In our view, Altria’s entry into the fast growing cannabis market and its potential stake in Juul, which accounted for about three-quarters of the US e-cigarette market, are two smart moves that will position the company to capture significant positions in each of these fast growing markets.

Cronos Group, currently Canada's number 6 pot producer, with its footprint in many countries and increasing production capabilities, has everything needed to become a strong global player in the marijuana space. The company is on track to grow 117,000 kilograms of cannabis per year, after the producer secured key supply agreements for the recreational marijuana market in Canada.

In addition, Cronos has partnered with pharmaceutical supplier Pohl-Boskamp to distribute medical cannabis products in Germany. It has also finalized another medical marijuana supply agreement in Poland. As well, the company has joint ventures in Australia, Israel, and Latin America.

Juul could prove to be a good investment for Altria too, as the start-up seeks to expand its e-cigarette business beyond the US where it’s facing significant regulatory hurdles. Juul products are sold in Canada, the UK, Israel and Russia; the company has expansion plans in Europe and Asia as well.

Despite the recent positive headlines, investors have generally given Altria's stock the cold shoulder. The primary reason: the FDA’s announcement last month that in addition to restricting e-cigarette sales it would seek to ban menthol cigarettes. Menthols represent about 20% of Altria’s cigarette sales.

Bottom Line

For the past few years, the negative headwinds hitting the tobacco industry have been accelerating. Not surprising then that it hasn't been a good time to invest in cigarette producers. But if you’re looking for regular income and long-term value from this sector, we believe Altria is the best option.

The company is fortifying its diversified business model which will help maintain earnings growth. With its 10% stake in Anheuser-Busch InBev (NYSE:BUD), the largest beer producer in the world, and a now sizeable position in the accelerating marijuana industry, Altria is a good long-term bet, especially when its dividend yield, at 6%, is at a multiyear high.

With Its New Marijuana Deal, Is Cigarette-Maker Altria Group Finally A Buy?
 

Related Articles

David Moenning
Has a New Bull Arrived? By David Moenning - Jan 30, 2023 4

In last week's meandering market missive, I opined that, "the next major trend - in either direction - is likely to be driven by the outlook/expectation for the state of the...

With Its New Marijuana Deal, Is Cigarette-Maker Altria Group Finally A Buy?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Marijus Balkaitis
Marijus Balkaitis Dec 12, 2018 5:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I see only sell on this chart.
George Angelopoulos
George Angelopoulos Dec 12, 2018 2:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i work in Manhattan restaurant,s and live in a working class part of the Bronx..nobody, and I mean nobody is drinking Budweiser products..it's all Coors light, modelo ,Corona and hieneken..
michael weaver
michael weaver Dec 12, 2018 2:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I live in the middle of Iowa, and and everybody, and I mean everybody drinks Bud light, Busch or Natural light. . Being from Wisconsin, it pains me to have a relatively hard time finding Miller products. . So that corner of NYC is just one area of a vast nation.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email